In patients with hemochromatosis and diabetes who are presumed or known to have pancreatic siderosis, phlebotomy therapy is likely to improve insulin secretion only when hemochromatosis diagnosis and iron depletion are early [15, 153, 154]. The gene discussed is INS; the disease is diabetes mellitus.